For ads-free news, click here.
From Breitbart: Pharmaceutical company Novartis announced plans to build seven facilities in the United States and expand others in a $23 billion investment over five years on the heels of President Donald Trump’s announcement of forthcoming tariffs on imported drugs.
The Swiss company revealed the major investment in a press release.
“This commitment enables Novartis to expand on its current manufacturing, research and technology presence across the country with 10 facilities, including 7 brand new facilities, creating nearly 1,000 new jobs at Novartis and approximately 4,000 additional US jobs,” the release said.
Below is an excerpt from the company’s press release:
The production capacity will cover both active pharmaceutical ingredients (API) and biologics drug substance, as well as secondary production and packaging.
Over the next 5 years, Novartis will:
- Establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US
- Build 4 new manufacturing facilities in soon-to-be-determined states, including 3 that will make biologics drug substances, drug products, device assembly and packaging, and 1 facility that will make chemical drug substances, oral solids dosage forms and packaging
- Build 2 new radioligand therapy (RLT) manufacturing facilities in Florida and Texas
- Expand 3 RLT manufacturing facilities in Indianapolis, IN, Millburn, NJ, and Carlsbad, CA
With these investments, Novartis will have manufacturing capacity in the US for all its core technology platforms, including small molecules and biologics. Novartis already manufactures its most innovative, advanced therapies in the US for patients in the US and around the world.
#News: We are expanding our US-based manufacturing and R&D footprint with a planned $23B investment over the next 5 years.
🔗 https://t.co/jGBfesZqhb #NovartisUS pic.twitter.com/lYfaETHFuW
— Novartis US (@NovartisUS) April 10, 2025
President Trump told reports in the Oval Office on Wednesday that he would be imposing tariffs on pharmaceutical imports, because they have to start making medicines in the U.S. He noted that during Covid, he learned that the U.S. is reliant on China for drugs and pharmaceuticals.
Reporter: Tariffs of pharmaceuticals, steel.. is that something you’re still considering moving forward with?
Trump: Yeah, I will be pic.twitter.com/RmSqIVKJ6E
— Acyn (@Acyn) April 9, 2025
TRUMP EFFECT: Novartis plans to invest $23 billion in US plants as Trump renews drug tariff threatshttps://t.co/2amc25Q44Y
— Rapid Response 47 (@RapidResponse47) April 10, 2025
Follow us on X (Formerly Twitter.)
The DML News App: www.X.com/DMLNewsApp
The Dennis Michael Lynch Podcast archive is available below, with the most recent on top. Never miss an episode. Subscribe to the show by downloading The DML News App or go to Apple Podcasts.
